SCHEMBL19203885

SCHEMBL19203885

CCCCCCCC[C@H](CCCCCCC)NC(=O)CCC(N)=O

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 2/20 0.61
DNM1 Q05193 1/20 0.57
PLA2G10 O15496 2/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
FAAH O00519 3/20 0.50
MAPK1 P28482 1/20 0.50
SOAT1 P35610 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
NOD1 Q9Y239 3/20 0.45
CPT2 P23786 1/20 0.44
CPT1A P50416 1/20 0.44
CPT1B Q92523 1/20 0.44
SLC6A5 Q9Y345 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9634134 0.93 DNM1 (0.54) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL31318140 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL31364557 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL2482500 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL27753924 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL25067268 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL6943359 0.87 PLA2G2C (0.67) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL30679514 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL27536177 0.87 PLA2G2C (0.77) PLA2G2CDNM1PLA2G10MEN1KMT2A
SCHEMBL11638748 0.86 FAAH (0.51) PLA2G2CDNM1PLA2G10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10415040-B2 Nucleic acid amphiphiles and nanostructures REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2019-09-17 US disclosed
US-20170218367-A1 NUCLEIC ACID AMPHIPHILES AND NANOSTRUCTURES REGENTS OF THE UNIVERSITY OF MINNESOTA 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10415040-B2 Nucleic acid amphiphiles and nanostructures EWSR1, ANXA4, POLRMT PLA2G2C 3329/4885DNM1 152/4885PLA2G10 3061/4885
US-20170218367-A1 NUCLEIC ACID AMPHIPHILES AND NANOSTRUCTURES EWSR1, ANXA4, POLRMT PLA2G2C 3329/4885DNM1 152/4885PLA2G10 3061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.